Publications by authors named "Shayang Luo"

Claim this Profile
E
Efficacy and safety of neoadjuvant treatment of trastuzumab and pyrotinib plus dalpiciclib in HR-negative/HER2-positive breast cancer: an exploratory, open-label phase II study.
Zhi Xiao, Feiyu Chen, Liqiu Liao, Shayang Luo, Xuan Liu, Na Luo

Int J Surg· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The application of aptamer 5TR1 in triple negative breast cancer target therapy.
Shayang Luo, Shouman Wang, Na Luo, Feiyu Chen, Chun Hu

J Cell Biochem· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relative dose intensity and therapy efficacy in different breast cancer molecular subtypes: a retrospective study of early stage breast cancer patients treated with neoadjuvant chemotherapy.
Jia-Qi Yuan, Shou-Man Wang, Li-Li Tang, Jie Mao, Yu-Hui Wu, Sha-Yang Luo, Na Luo

Breast Cancer Res Treat· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin D receptor gene ApaI polymorphism and breast cancer susceptibility: a meta-analysis.
Shayang Luo, Lei Guo, Yan Li, Shouman Wang

Tumour Biol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Expressions of survivin and nm23 and the relationship among the expressions and the axillary lymph node metastasis in breast cancer].
Jie Mao, Jian Hai, Heng-Ping Shu, Yu-Hui Wu, Hui-Yin Ou, Sha-Yang Luo

Zhong Nan Da Xue Xue Bao Yi Xue Ban· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis